• Responsible for all HCP personal and non-personal promotional tactics for PADCEV launch under FDA’s Accelerated Approval program • Led launch tactical planning across Seattle Genetics and Astellas Pharma involving Medical, Sales, Access, Advocacy, and Corporate Communications functions across both companies• Planned and executed comprehensive disease state education campaign including sales deployment strategy/training and all non-personal / media strategy and tactics

• Built brand team from the ground up by hiring team of three marketers • Commercial lead on Joint Project Team with external partners developing companion diagnostics to drive alignment on launch strategy, tactics and sales deployment• Led Advisory Boards and roundtables with key customers to design tools and resources to accelerate account onboarding at launch

• Led brand planning process across Medical Affairs and Commercial teams resulting in board approved launch strategies and tactics• Provided commercial input in FDA label development and negotiations resulting in better differentiation of brand from competitive agents and easier sales rep training• Planned, developed content for, and executed disease state education initiatives including a corporate symposium attended by 500 prescribers • Engaged with advocacy groups to evaluate sponsorship opportunities to further patient/caregiver education• Provided commercial leadership on cross-functional product teams to ensure commercial considerations are contemplated in optimizing product development plans• Establish and execute the primary and secondary market research and competitive intelligence plan to guide marketing, sales, and market access strategies, as well as the revenue forecast for current pipeline and new products

- Head of Business Analytics department reporting directly to CBO- Built department from the ground up: Hired a team to cover market research, forecasting, salesforce sizing, national/regional dashboards and competitive intelligence competencies

• Forecasting: Led Delphi workshops with senior management including CEO to develop long-range patient, revenue, and SKU forecasts in launch year; influenced corporate sales goal approval by Board of Directors through sensitivity and waterfall analysis• Market Research: Improved launch year marketing strategies and tactic effectiveness by insights gleaned from qualitative and quantitative market research; drove consensus among internal and Takeda stakeholders on annual research budget• Situation Analysis: Monitored and predicted market and competitive trends including biosimilars by developing KITs/KIQs and competitor profiles, and holistically assessing primary and secondary data• Business Development: Made recommendations to senior management on acquisition targets and lifecycle extensions using scenario-based forecasts; recommendations were adopted• Corporate Communications: Influenced corporate communications strategy by comparing internal sales performance, IMS and WK/SHA data and Wall Street investment theses

• Pipeline Strategy: Prioritized commercial potential of four pipeline segments for $11B market by conducting qualitative and quantitative market research• Go-to-market Strategy: Optimized product launch and physician targeting strategy by segmenting physicians and modeling patient flow across physician specialties• Sales Training: Co-led summit for 20 person client marketing and sales teams to improve target customer messages by operationalizing customer segmentation findings • Due Diligence: Prioritized acquisition targets for $4.5B pharmaceutical client based on market share and pricing scenarios gathered through primary research

• Customer Requirements: Designed a customer coverage, segmentation and intelligence initiative to increase sales force effectiveness for a diagnostics company

• Project management: Led cross-site change management operation as part of global taskforce resulting in three-fold increase in development speed and two-fold increase in product quality • Collaborative Design: Received Outstanding Performance Award for fast-tracking software development by negotiating with marketing and clinical groups to attain early consensus on requirements• R&D: Designed new features for implantable defibrillators against existing 90 features and mitigated hazardous interactions among features • Management: Managed team of 12 cross-functional engineers to successfully develop software algorithms for implantable defibrillators; secured Special Achievement Awards for 4 members of team

• Operations engineering: Analyzed client business processes and implemented practices to enhance customer experience and reduce billing inefficiencies